+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Lewy Body Dementia Treatment Market by Drug Type, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674515
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Lewy Body Dementia Treatment Market grew from USD 6.12 billion in 2023 to USD 6.60 billion in 2024. It is expected to continue growing at a CAGR of 8.54%, reaching USD 10.87 billion by 2030.

Lewy Body Dementia (LBD) treatment encompasses a range of pharmaceutical and therapeutic interventions designed to manage symptoms associated with this progressive neurodegenerative disorder, which affects cognitive, motor, and behavioral functions. The necessity for effective LBD treatments is underscored by the growing elderly population and increasing prevalence of neurodegenerative diseases. Treatments aim to alleviate symptoms like memory loss, motor rigidity, and hallucinations, improving patients' quality of life. The end-use scope includes applications in hospitals, clinics, and home care settings, with stakeholders comprising neurologists, geriatric specialists, and caregivers. The market is propelled by advances in neuropharmacology, increasing awareness about LBD, and ongoing research into novel therapeutics such as cholinesterase inhibitors and antipsychotics tailored for dementia-related psychosis. Key growth influencers include technological advancements in precision medicine, supportive government healthcare policies, and the integration of telemedicine in treatment regimens. However, substantial challenges persist, including high R&D costs, limited treatment efficacy, underdiagnosis, and misdiagnosis of LBD. Furthermore, the dearth of approved, targeted treatments remains a hurdle. Capturing potential opportunities involves investing in biomarker identification for early diagnosis, developing personalized medicine approaches, and leveraging artificial intelligence for drug discovery. Companies can also explore alliances with academic institutions for innovative collaborative research. Innovating in cognitive training software and non-invasive brain stimulation therapies are promising areas for development. Understanding the market nature reveals a competitive landscape marked by a handful of major pharmaceutical players, with rising competition from emerging biotech firms. Ultimately, prioritizing patient-centric approaches and fostering interdisciplinary research collaborations will be crucial for stakeholders aiming to expand their footprint in the LBD treatment market. Recommendations include focusing on enhancing diagnostic accuracy and pursuing regulatory pathways that facilitate quicker market access for new therapeutics.

Understanding Market Dynamics in the Lewy Body Dementia Treatment Market

The Lewy Body Dementia Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of lewy body dementia and absence of concerned drug
    • Government initiatives for creating awareness about lewy body dementia
    • Favorable reimbursement regulations pertaining to lewy body dementia treatment
  • Market Restraints
    • High treatment cost along with need of long term care
  • Market Opportunities
    • Burgeoning number of performed clinical trials for lewy body dementia treatment
    • Growing healthcare facilities in countries
  • Market Challenges
    • Possible adverse effects of drugs

Exploring Porter’s Five Forces for the Lewy Body Dementia Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Lewy Body Dementia Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Lewy Body Dementia Treatment Market

External macro-environmental factors deeply influence the performance of the Lewy Body Dementia Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Lewy Body Dementia Treatment Market

The Lewy Body Dementia Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Lewy Body Dementia Treatment Market

The Lewy Body Dementia Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Lewy Body Dementia Treatment Market

The Lewy Body Dementia Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lewy Body Dementia Treatment Market, highlighting leading vendors and their innovative profiles. These include Axovant Sciences Ltd., Bausch Health Companies Inc., Bayer AG, BioArctic AB, Eisai Co., Ltd., Eli Lilly and Company, Immungenetics AG, Jazz Pharmaceuticals, Inc, Mallinckrodt Pharmaceuticals, Novartis AG, Noven Pharmaceuticals, Inc, Pfizer Inc, Sumitomo Dainippon Pharma Co., Ltd, and Takeda Pharmaceutical Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Lewy Body Dementia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Drug Type
    • Antidepressants
    • Antipsychotic Drugs
    • Benzodiazepine
    • Carbidopa-Levodopa
    • Cholinesterase Inhibitors
      • Donepezil
      • Galantamine
      • Rivastigmine
    • Modafinil
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
  • Application
    • Alzheimer’s Disease
    • Dementia
    • Parkinson's Disease
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lewy body dementia and absence of concerned drug
5.1.1.2. Government initiatives for creating awareness about lewy body dementia
5.1.1.3. Favorable reimbursement regulations pertaining to lewy body dementia treatment
5.1.2. Restraints
5.1.2.1. High treatment cost along with need of long term care
5.1.3. Opportunities
5.1.3.1. Burgeoning number of performed clinical trials for lewy body dementia treatment
5.1.3.2. Growing healthcare facilities in countries
5.1.4. Challenges
5.1.4.1. Possible adverse effects of drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Lewy Body Dementia Treatment Market, by Drug Type
6.1. Introduction
6.2. Antidepressants
6.3. Antipsychotic Drugs
6.4. Benzodiazepine
6.5. Carbidopa-Levodopa
6.6. Cholinesterase Inhibitors
6.6.1. Donepezil
6.6.2. Galantamine
6.6.3. Rivastigmine
6.7. Modafinil
7. Lewy Body Dementia Treatment Market, by Distribution Channel
7.1. Introduction
7.2. Online Pharmacies
7.3. Retail Pharmacies
8. Lewy Body Dementia Treatment Market, by Application
8.1. Introduction
8.2. Alzheimer’s Disease
8.3. Dementia
8.4. Parkinson's Disease
9. Americas Lewy Body Dementia Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Lewy Body Dementia Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Lewy Body Dementia Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. LEWY BODY DEMENTIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 9. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. LEWY BODY DEMENTIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. LEWY BODY DEMENTIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. LEWY BODY DEMENTIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. LEWY BODY DEMENTIA TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ANTIPSYCHOTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY BENZODIAZEPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CARBIDOPA-LEVODOPA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DONEPEZIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY GALANTAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY MODAFINIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 40. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 44. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 62. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CHINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 66. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. INDIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 74. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. JAPAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 98. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. THAILAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 111. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. DENMARK LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 115. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. EGYPT LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 119. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FINLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 123. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 135. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 147. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. NORWAY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 151. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. POLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 155. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. QATAR LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 183. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. TURKEY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. LEWY BODY DEMENTIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. LEWY BODY DEMENTIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Lewy Body Dementia Treatment Market, which are profiled in this report, include:
  • Axovant Sciences Ltd.
  • Bausch Health Companies Inc.
  • Bayer AG
  • BioArctic AB
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Immungenetics AG
  • Jazz Pharmaceuticals, Inc
  • Mallinckrodt Pharmaceuticals
  • Novartis AG
  • Noven Pharmaceuticals, Inc
  • Pfizer Inc
  • Sumitomo Dainippon Pharma Co., Ltd
  • Takeda Pharmaceutical Company Ltd.

Methodology

Loading
LOADING...

Table Information